Viral kinetic of HCV genotype-4 during pegylated interferon alpha 2a: ribavirin therapy-Reference-Cited by-同舟云学术

Viral kinetic of HCV genotype-4 during pegylated interferon alpha 2a: ribavirin therapy

Published:2008-08 Issue:8 Volume:15 Page:591-599
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:

Author:

Derbala M. F.,El Dweik N. Z.,Al Kaabi S. R.,Al-Marri A. D.,Pasic F.,Bener A. B.,Shebl F. M.,Amer A. M.,Butt M. T.,Yakoob R.,John A.,Al Mohanadi M.,Al Khinji M. A.

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2893.2008.00988.x/fullpdf

Reference28 articles.

1. National Institutes of Health Consensus Development Conference statement: management of hepatitis C;National Institutes of Health;Hepatology,2002

2. Peginterferon-alpha 2a and Ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and Ribavirin dose;Hadziyannis;Ann Intern Med,2004

3. Predicting the therapeutic response in patients with chronic hepatitis C: the role of viral kinetic studies;Ferenci;J Antimicrob Chemother,2004

4. Differences in viral dynamics between genotypes 1 and 2 hepatitis C virus;Neumann;J Infect Dis,2000

5. Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection;Legrand-Abravanel;J Med Virol,2005

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver Transplantation and HCV Genotype 4;Advances in Hepatology;2021-07-28

2. Spur-of-the-Moment Modification in National Treatment Policies Leads to a Surprising HCV Viral Suppression in All Treated Patients: Real-Life Egyptian Experience;Journal of Interferon & Cytokine Research;2018-02

3. Integrated pharmacokinetic/viral dynamic model for daclatasvir/asunaprevir in treatment of patients with genotype 1 chronic hepatitis C;Acta Pharmacologica Sinica;2017-09-07

4. Management of hepatitis c genotype 4 in the liver transplant setting;Saudi Journal of Gastroenterology;2016

5. Sustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: a meta-analysis;BMJ Open Gastroenterology;2015-12-31